Insilico Medicine, a company that specialises in the development of artificial intelligence for drug discovery and development, announced the launch of a new system for COVID-19 basic and clinical research
Darren Barrington-Light, senior product marketing manager, eCDS, Thermo Fisher Scientific discusses the importance of cloud-based data management for effective collaboration and operational efficiency.
Elsevier has announced that it has acquired SciBite, a semantic AI company headquartered in Cambridge, UK, that helps customers discover insights in life science data through the use of text and data intelligence software.
North Carolina School of Science and Mathematics (NCSSM) and Optibrium celebrate five years of collaboration to support education
Atos and the Wellcome Genome Campus, in Cambridgeshire, UK, have announced a partnership to provide a global HPC, AI & Quantum Life Sciences Centre of Excellence to give researchers access to emerging HPC, AI & Quantum technologies
CAS, a division of the American Chemical Society specialising in scientific information solutions has partnered with the Pistoia Alliance to develop and host the Pistoia Alliance Chemical Safety Library
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
Optibrium and OpenEye Scientific (OpenEye), have announced integration between their two software platforms to provide scientists with new added funcionality for small molecule drug discovery
L7 Informatics and Contamination Source Identification (CSI) have announced a partnership to accelerate the implementation of testing for COVID-19 patient screening
Two new research papers from The University of Manchester, working with colleagues at Sellafield Limited and the National Nuclear Laboratory have shown that microbes can actively colonise some of the most intensively radioactive waste storage sites in Europe
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
